Health-related quality of life in relapsing remitting multiple sclerosis (RRMS) patients treated with placebo or BG-12 (dimethyl fumarate): comparison with other medical conditions

被引：0
|
作者：
Sarda, S.
Phillips, G.
Gaebler, J. A.
Kurukulasuriya, N. C.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Interim analysis of quality of life in patients with relapsing remitting multiple sclerosis treated with BG-12 (dimethyl fumarate) in the ENDORSE study
    Kita, M.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Sarda, S. P.
    Kong, J.
    Zhang, R.
    Viglietta, V.
    Sheikh, S. I.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 530 - 530
  • [2] Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
    Kita, Mariko
    Fox, Robert J.
    Phillips, J. Theodore
    Hutchinson, Michael
    Havrdova, Eva
    Sarda, Sujata P.
    Agarwal, Sonalee
    Kong, Jessica
    Zhang, Annie
    Viglietta, Vissia
    Sheikh, Sarah I.
    Seidman, Emily
    Dawson, Katherine T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 253 - 257
  • [3] Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study
    Kappos, Ludwig
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Sarda, Sujata P.
    Agarwal, Sonalee
    Zhang, Annie
    Sheikh, Sarah I.
    Seidman, Emily
    Dawson, Katherine T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 243 - 252
  • [4] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral BG-12 (Dimethyl Fumarate) in DEFINE and CONFIRM
    Meltzer, Leslie
    Selmaj, Krzysztof
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Pace, Amy
    Novas, Mark
    Hotermans, Christophe
    Dawson, Katherine
    Phillips, J. Theodore
    NEUROLOGY, 2013, 80
  • [5] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral Bg-12 (Dimethyl Fumarate) in Define and Confirm
    Bar-Or, A.
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Kurukulasuriya, N. C.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1840 - 1841
  • [6] Lymphocyte count reductions in relapsing remitting multiple sclerosis (RRMS) patients treated with oral BG-12 (dimethyl fumarate): integrated analysis of the placebo-controlled studies
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Raghupathi, K.
    Yuan, H.
    O'Gorman, J.
    Novas, M.
    Viglietta, V.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 469 - 469
  • [7] Effect of BG-12 (dimethyl fumarate) in newly diagnosed relapsing remitting multiple sclerosis (RRMS) patients from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 453 - 454
  • [8] Effects of BG-12 (Dimethyl Fumarate) on Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Sarda, Sujata
    Kong, Jessica
    Viglietta, Vissia
    Sheikh, Sarah
    Dawson, Katherine
    Kappos, Ludwig
    NEUROLOGY, 2013, 80
  • [9] Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis
    Kappos, Ludwig
    Giovannoni, Gavin
    Gold, Ralf
    Fox, Robert
    Phillips, J. Theodore
    Hotermans, Christophe
    Zhang, Annie
    Viglietta, Vissia
    Miller, David
    NEUROLOGY, 2013, 80
  • [10] Flushing and gastrointestinal tolerability events in relapsing remitting multiple sclerosis (RRMS) patients treated with oral BG-12 dimethyl fumarate) in the phase 3 DEFINE and CONFIRM trials
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Giovannoni, G.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Viglietta, V.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 221 - 221
12345